SOURCE: Xtalks

Xtalks Webinars

September 21, 2017 07:00 ET

Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - September 21, 2017) - It's an exciting time for the life sciences industry, with technology driving greater levels of efficiency, effectiveness and patient engagement and satisfaction in clinical trials.

Electronic informed consent (eConsent) is quickly gaining a reputation for being the next big technological innovation in clinical trials. With both regulators and industry groups advocating the impressive benefits of eConsent, it is no surprise that 66% of top 50 pharma companies are engaged or planning an eConsent initiative in the near future, with all 10 of the top 10 already having an eConsent strategy in place.

In order to benchmark current eConsent use, gauge experiences and expectations, better understand adoption hurdles and challenges, and anticipate how eConsent use will grow in the future, CRF Health conducted the first-ever State of eConsent Industry Survey. Following that survey, CRF Health released its site edition of the survey, gathering site staff opinions on the impacts of paper-based informed consent and eConsent.

During this webinar, Sandra "Sam" Sather from CRF Health and special guest, Giga Smith, from Coastal Carolina Health Care (CCHC), reveal the results of CRF Health's "Electronic Informed Consent: 2017 Industry Survey Results - Site Edition." This site-specific survey gathered feedback from 105 respondents in roles including study coordinator, clinical research associate (CRA), investigator, and researcher. Topics covered include:

  • Participant compliance
  • Time to complete the consent form
  • Participants' most frequently asked questions
  • Negative impact of paper consent forms
  • Reasons for refusing consent
  • Reasons for dropping out of a consent
  • Impact of eConsent on drop outs
  • eConsent usefulness
  • Effects of eConsent on participant recruitment
  • Current eConsent use
  • Perceived impact of eConsent

Plus, Giga Smith provides insights into the responsibilities of a site and how adding eConsent technology brings challenges and benefits. Giga's experience with a variety of consent formats provides a real-world view into how to successfully implement strategies to adopt eConsent with minimal issues. A checklist of items to consider gathering from sponsors and vendors will also be discussed.

The input from a site perspective can prevent some major issues when implementing a new technology. Whether your organization is just starting to consider eConsent or looking to expand adoption, these survey findings will provide valuable insight and context into the perspectives of site staff.

Join the live discussion on Tuesday, October 10, 2017 at 11am EDT (4pm BST/UK). For more information visit: Electronic Informed Consent: 2017 Industry Survey Results from Clinical Sites


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit:

For information about hosting a webinar visit:

Image Available:

Contact Information